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We  report  a case  of a  nine-year-old  boy  with  a 4-week  history  of  general  fatigue,  loss  of  appetite,  vomits
and  hematemesis.  Laboratory  evaluation  revealed  a hemoglobin  level  of 4.4  g/dl.  After  a  transfusion  of
packed  red  blood  cells  the  patient  underwent  an  esophagogastroduodenoscopy,  which  showed  a  smooth,
rounded  6–8  cm submucosal  lesion  with  a central  depression  with  ulceration  and  active  bleeding  in  the
cardia  extending  to  the  fundus.
Computed tomography  (CT)  of the  chest,  abdomen  and  pelvis  showed  a large  mass  originating  from
the  gastric  wall  but not  inﬁltrating  surrounding  organs,  approximately  8.0  cm × 7.0 cm  ×  5 cm.  Despitebdominal tumor
ubmucosal tumors
astrointestinal bleeding
-KIT
hildren
astric
iagnosis
the  tumor  size,  no  metastases  were  diagnosed.  The  patient  underwent  a  total  gastrectomy  in  an  en-
bloc  resection  including  the  distal  part of the  esophagus  (3 cm)  and  omentum  with  oncologic  margins.
Reconstruction  was  performed  with  a mediastinal  end-to-side  esophago-jejunal  anastomosis.  Immune-
histochemic  conﬁrmed  GIST.  He  remains  well  without  evidence  of  disease  after  36  months  of  follow-up
with  a multiprofessional  team.
© 2011 Surgical Associates Ltd. Elsevier Ltd. Open access under CC BY-NC-ND license.. Introduction
Gastrointestinal stromal tumors (GIST) are uncommon mes-
nchymal neoplasms that are typically described in adults older
han 40 years with a peak incidence in the sixth and seventh
ecades.1 These tumors seem to be very rare in children and young
dults. They have malignant potential, but their behavior has been
ifﬁcult to predict. Furthermore, the clinical characteristics of GIST
n children and differences between adult and child cases are not
learly understood.2
We  report a case of a gastric GIST in a 9-year-old boy
ho presented with anemia and gastrointestinal bleeding. Endo-
copic ﬁndings, clinical course, differential diagnosis and treatment
ptions are reviewed.
.  Case reportA  nine-year-old boy presented with general fatigue, loss of
ppetite and vomiting as for the last four weeks was  referred to our
ospital after an episode of hematemesis. He had no contributory
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Open access under CC BY-NC-ND licenmedical history and family history for cancer or other chronic dis-
eases was negative. The parents reported loss of 4 kg of body in a
month. There was  no history of melena or trauma. Initial exami-
nation was  notable for pallor, lethargy and tachycardia (140 beats
per minute – bpm). His abdominal examination was unremarkable
(Fig. 1).
Laboratory evaluation revealed a hemoglobin level of 4.4 g/dl,
platelet count of 871,000 cells/mm,3 normal results of coagulation
studies and metabolic screening. After a transfusion of packed red
blood cells (300 ml)  the patient underwent an esophagogastroduo-
denoscopy, which showed a smooth, rounded 6–8 cm submucosal
lesion with a central depression with ulceration and active bleed-
ing in the cardia (posterior) extending to the fundus. Biopsies were
inconclusive.
Computed tomography (CT) of the chest, abdomen and pelvis
showed a large mass originating from the gastric wall but not inﬁl-
trating surrounding organs, approximately 8.0 cm × 7.0 cm × 5 cm
(Fig. 2). Tumor markers such as -fetoprotein, CEA and Ca19-9 were
not elevated. After stabilization with blood transfusion and saline
solution, surgery was planned.
The  patient underwent a median laparotomy with a total
gastrectomy in an en-bloc resection including the distal part
of the esophagus (5 cm)  and omentum with oncologic margins
(D2 resection). Reconstruction was  performed with a Roux-en-Y
esophago-jejunal anastomosis. A nasoenteric tube was placed for
early enteral feeding. No liver metastasis or other abnormalities
was seen in the abdominal cavity (Figs. 2 and 3).
se.
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Fig. 1. (A) Plain chest radiography with a image of a lesion inside the stomach. (B)
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Fig. 2. (A) Operative image after opening the anterior gastric wall. (B) View of theomputed tomography (CT) of the abdomen showing a large mass originating from
he gastric wall but not inﬁltrating surrounding organs.
Early enteral feeding was initiated on the third postoperative
ay. Barium swallow with follow-through in the 11th postoperative
ay showed anastomosis with no abnormalities and oral feed-
ng was began. The postoperative course was uneventful and the
atient was released 20 days after surgery.
The histology assessment was suggestive of a GIST with a
educed mitotic index. In immunehistochemical staining, the
umor stained positive for c-KIT (CD-117) and actin 1 to 4, but neg-
tive for PS-100, desmine and vimentine. From these ﬁndings, the
iagnosis of GIST was made. All margins were negative for tumor
nvolvement.
The patient was followed monthly. CT of abdomen after 12 and
4 months showed no disease.
The patient is using ferrous sulfate and vitamin B12, is gaining
eight and laboratory tests are normal. He remains well without
vidence of disease after 36 months of follow-up (Fig. 4).
.  Discussion
GISTs are the most common mesenchymal tumor of the gas-
rointestinal tract in adults. Pediatric GIST cases are rare and have
een reported to represent only 1.4% of all GIST cases. The classiﬁca-
ion as a GIST requires immunohistochemical assays, characterized
s being uniformly positive for stem cell factor CD34 and c-kit
CD-117), variably positive for S-100 and negative for desmin.posterior gastric wall. (C) Total gastrectomy being performed using a linear stapler.
This distinguishes GISTs from other gastrointestinal smooth muscle
tumors such as leiomyomas and leiomyosarcomas.1,3
Literature describes GISTs arising from the interstitial cells of
Cajal, a cell having neural and muscular attributes, which primary
functions as the pacemaker for muscular motility of the gastroin-
testinal tract. Both the interstitial cells of Cajal and GIST cells
express the receptor tyrosine kinase KIT and the immunohisto-
chemical marker for KIT (CD-117).2,3
In adults, the occurrence of metastatic disease is rare. However
in children metastases are seen at the time of diagnosis in more than
450% of pediatric patients. Liver involvement or multifocal omen-
tal implants has been described as the most common location of
metastatic spread. GISTs can occur anywhere along the gastroin-
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estinal tract, including stomach (70%), small intestine (20–30%),
norectum (7%), colon, and esophagus.2
Presenting signs and symptoms are variable depending on the
ize and anatomic location of the tumor and can include abdominal
ain, hematemesis, melena, and anemia from occult gastrointesti-
al bleeding.4
The use of CT or abdominal ultrasound has been the most
requently used imaging tools to establish the diagnosis of GIST.
ypically, the lesion is a lobulated, irregular, intraluminal mass,
hich contains ulcerations and which may  be quite large. Further
maging such as CT and MRI  are indicated to show the exophytic
omponent of this tumor as well as the presence of hepatic metas-
ases. CT shows a rounded, low-attenuation mass, which does not
nhance with intravenous contrast. MRI  shows a rounded increased
2 signal mass that does not signiﬁcantly enhance with intravenousFig. 4. Esofagogram after 2 years with no abnormalities.
gadolinium and can be helpful in conﬁrming gastric origin and
identifying multifocal disease.1
GIST appears as a submucosal mass of varying size with nor-
mal overlying mucosa in esophagogastroduodenoscopy. Although
endoscopic biopsy of the mass can be performed, in some cases may
not yield enough deep tissue to establish the diagnosis. Because
of the depth of involvement of the lesions, snare resection is
usually not possible and may result in gastric perforation and
uncontrollable bleeding. Endoscopic ultrasound (EUS) is precise for
distinguishing different types of submucosal masses.1
Prognostic factors for GISTs include location, size, and histol-
ogy. A majority of these tumors are clinically indolent with an
excellent long-term prognosis. Tumors that are larger than 5 cm
are also thought to be associated with worse survival. The likeli-
hood of metastatic disease correlates with tumor size and degree
of mitotic activity: one mitosis or fewer per 10 (higher power ﬁelds
(HPF) is considered to be low grade, whereas 2 or more mitoses per
10 HPF is thought to have a greater malignant potential.3–6
Surgical resection is considered the current standard of care
for GIST, and lymphadenectomy has not been shown to improve
survival.3 Although the response to conventional chemotherapy
and radiotherapy is poor, the oral protein kinase inhibitor, imatinib
mesylate, has shown promising antiproliferative and apoptotic
effects and may  be beneﬁcial for patients with GISTs, particu-
larly those with recurrent metastatic disease.1,4 The indication for
adjuvant imatinib mesylate therapy has not been established in
pediatric GIST cases thus far.4 Because of the infrequency of GIST
in pediatric patients, there is currently no standardized treatment
protocol.1,7
The 5-year survival rates for GISTs have ranged from 32% to
63% after complete surgical resection. Treatable recurrences are not
uncommon and may  reﬂect initial insufﬁcient excision or multifo-
cal disease escaping surgical detection at the outset.
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Imaging postoperative surveillance is performed with magnetic
esonance, CT and positron emission tomographic scanning to eval-
ate for recurrent disease.
.  Conclusion
Gastrointestinal stromal tumor in children are rare but should
e considered in the etiology of bleeding and submucosal gas-
ric masses, specially in the gastric antrum. It may  present with
cute gastrointestinal bleeding, chronic gastrointestinal blood loss,
nemia, abdominal pain and left upper quadrant abdominal mass.
ISTS tends to be more aggressive in pediatric population, being
urgical resection the best current standard of care.
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